Arcosa Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Arcosa stock.
View analyst ratings for Arcosa or view top-rated stocks.

Wall Street analysts have given Arcosa a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Arcosa wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Arcosa.

Arcosa will be holding an earnings conference call on Thursday, August 5th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-220-7233.

Arcosa, Inc. (NYSE:ACA) issued its quarterly earnings results on Thursday, April, 29th. The company reported $0.35 EPS for the quarter, topping the Zacks' consensus estimate of $0.21 by $0.14. The company earned $440.40 million during the quarter, compared to analysts' expectations of $439.40 million. Arcosa had a net margin of 4.82% and a trailing twelve-month return on equity of 5.45%.
View Arcosa's earnings history.

Arcosa's stock was trading at $37.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACA shares have increased by 47.8% and is now trading at $54.76.
View which stocks have been most impacted by COVID-19.

Arcosa announced a quarterly dividend on Tuesday, May 4th. Shareholders of record on Thursday, July 15th will be paid a dividend of $0.05 per share on Friday, July 30th. This represents a $0.20 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend is Wednesday, July 14th.
View Arcosa's dividend history.

Arcosa pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.36%. Arcosa does not yet have a strong track record of dividend growth. The dividend payout ratio of Arcosa is 8.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Arcosa will have a dividend payout ratio of 8.16% next year. This indicates that Arcosa will be able to sustain or increase its dividend.
View Arcosa's dividend history.

Arcosa updated its FY 2021 earnings guidance on Thursday, May, 6th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $1.88 billion-$2 billion, compared to the consensus revenue estimate of $1.91 billion.

6 Wall Street analysts have issued 1-year price objectives for Arcosa's shares. Their forecasts range from $61.00 to $75.00. On average, they anticipate Arcosa's stock price to reach $69.25 in the next year. This suggests a possible upside of 26.5% from the stock's current price.
View analysts' price targets for Arcosa or view top-rated stocks among Wall Street analysts.

15 employees have rated Arcosa CEO Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among Arcosa's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Arcosa include Valmont Industries (VMI), Proto Labs (PRLB), HC2 (HCHC), Gulf Island Fabrication (GIFI), TechPrecision (TPCS) and Williams Industries (WMSI).
View all of ACA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), The Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by a variety of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (0.17%), TCW Group Inc. (0.09%), State of Alaska Department of Revenue (0.07%), Aptus Capital Advisors LLC (0.07%) and Harel Insurance Investments & Financial Services Ltd. (0.03%). Company insiders that own Arcosa stock include Antonio Carrillo, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold Arcosa company stock in the last year include Jesse E Jr Collins, Mary E Henderson, and Ronald J Gafford.
View insider buying and selling activity for Arcosa or view top insider-selling stocks.

ACA stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Aptus Capital Advisors LLC, TCW Group Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Arcosa or or view top insider-buying stocks.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACA stock can currently be purchased for approximately $54.76.

Arcosa has a market capitalization of $2.64 billion and generates $1.94 billion in revenue each year. The company earns $106.60 million in net income (profit) each year or $2.45 on an earnings per share basis.

Arcosa employs 6,410 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa is headquartered at 500 N. Akard Street Suite 400, DALLAS TX, 75201.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at (972) 942-6500 or via email at [email protected]